While irritability is not officially listed as a common side effect, the way semaglutide interacts with certain hormones and brain functions may explain why some people feel more easily frustrated, anxious, or emotionally sensitive while using the medication
Glucagon-like peptide-1 (GLP-1) receptor agonists are a newer class of diabetes drugs that have the potential to double as weight loss drugs, widening their lucrative market potentials
Preclinical signals regarding potential effects on thyroid C-cells (observed with GLP-1 agonists as a class), as well as theoretical questions about bone metabolism and cardiovascular function, are being monitored in ongoing trials
A separate trial combining exercise with liraglutide produced the greatest total weight loss among treatment arms while preserving lean mass, whereas liraglutide alone was associated with loss of both fat and lean tissue
Tracking intake with a food diary or app can help spot hidden calories and keep portions in check
GLP-1 medications include commonly used names like Ozempic, Wegovy and Mounjaro, which were although originally designed for diabetes treatment, are now used majorly as weight loss drugs